Related Experiment Videos
Small cell lung cancer: current status of new chemotherapeutic agents
1Division of Hematology/Oncology, VA Northern California Health Care System, Martinez 94553, USA.
Critical Reviews in Oncology/Hematology
|July 3, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study.
European journal of cancer (Oxford, England : 1990)·2018
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling.
Clinical and translational science·2016
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas.
British journal of cancer·2015
Innovative Clinical Trials: The LUNG-MAP Study.
Clinical pharmacology and therapeutics·2015
Clinical Management of Oral Potentially Malignant Disorders: State of the Art Review and Proposal for a New Framework.
Critical reviews in oncology/hematology·2026
Targeting intracellular immune regulatory molecules for cancer immunotherapy in solid tumors.
Critical reviews in oncology/hematology·2026
Spatial Heterogeneity in Anaplastic Thyroid Carcinoma: Mechanistic Insights and Clinical Translation through Single-Cell and Spatial Transcriptomics.
Critical reviews in oncology/hematology·2026
Predictive biomarkers in cancer immunotherapy for genitourinary malignancies.
Critical reviews in oncology/hematology·2026
The double-edged sword of PD‑1/PD‑L1 blockade: Bridging hepatocellular carcinoma to liver transplantation while minimizing allograft injury.
Critical reviews in oncology/hematology·2026
Cytokine‑driven modulation of immune checkpoint therapy response in colorectal cancer.
Critical reviews in oncology/hematology·2026